| ALT | Alanine aminotransferase |
| ANA | Antinuclear antibodies |
| ASS | Anti-synthetase syndrome |
| AST | Aspartate aminotransferase |
| BDI-II | Beck’s Depression Inventory-II |
| CADM | Clinically amyopathic dermatomyositis |
| CG | Control group |
| CK | Creatine phosphokinase |
| CRP | C-reactive protein |
| CXCL10 | C-X-C motif chemokine ligand 10, also known as IP-10 |
| DM | Dermatomyositis |
| ELISA | Enzyme-linked immunosorbent assay |
| ESR | Erythrocyte sedimentation rate |
| FGF | Fibroblast growth factor |
| FI-2 | Functional Index-2 |
| FIS | Fatigue Impact Scale |
| FVA | Force vector area |
| G-CSF | Granulocyte colony-stimulating factor |
| GM-CSF | Granulocyte-macrophage colony-stimulating factor |
| HAQ | Health Assessment Questionnaire |
| HCK | Hematopoietic cell kinase |
| Hsp90 | Heat shock protein 90 |
| IBM | Inclusion body myositis |
| IFN | Interferon |
| IG | Intervention group |
| IIM | Idiopathic inflammatory myopathies |
| IL | Interleukin |
| IMNM | Immune-mediated necrotizing myopathy |
| JAK | Janus kinase |
| LD | Lactate dehydrogenase |
| MAA | Myositis associated antibodies |
| MAPK | Mitogen-activated protein kinase |
| MCP-1 | Monocyte chemoattractant protein-1, also known as CCL2 |
| MIP-1α | Macrophage inflammatory protein-1α, also known as CCL3 |
| MIP-1β | Macrophage inflammatory protein-1β, also known as CCL4 |
| MMT-8 | Manual Muscle Testing of eight muscle groups |
| MSA | Myositis specific antibodies |
| NF-kB | Nuclear factor kappa-light-chain-enhancer of activated B cells |
| OM | Overlap myositis |
| PDGF | Platelet-derived growth factor |
| PM | Polymyositis |
| RANTES | Regulated on activation/normal T cell expressed and secreted, or CCL5 |
| Ras | Rat sarcoma protein, or Ras GTPase protein |
| SF-36 | Medical Outcomes Study 36-item Short Form Health Survey |
| STAT | Signal transducer and activator of transcription |
| TNF | Tumor necrosis factor |
| VEGF | Vascular endothelial growth factor |
| w | weeks |